HORSHOLM, Denmark--(BUSINESS WIRE)--LifeCycle Pharma A/S (OMX:LCP) announced today that Dr. Michael Beckert has decided to resign as EVP and CMO of LifeCycle Pharma in order to pursue other opportunities outside LCP effective December 31, 2008. Dr. Karin Hamberg, who is currently EVP of Drug Delivery Research and Alliance & Project Management, will assume responsibility for Clinical, Regulatory, and Medical Affairs undertaking Dr. Beckert’s responsibilities. Dr. Hamberg will be registered with the Danish Commerce and Companies Agency as member of the management board.
